Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Preventing type 1 diabetes – the main goal for some who do not believe a cure is possible – would ultimately bring this ancient disease to its end. The world’s top...
A fascinating session at the EASD 2022 conference on emerging technologies shed light on where we are with AID and telemedicine, and what leading researchers in diabetes...
diaTribe is excited to bring you additional expanded coverage from the EASD 2022 conference! Hear from leading clinicians and researchers around the world on insights...
An actively recruiting clinical trial is seeking to evaluate a new drug to treat diabetic kidney disease (DKD). This new injectable drug will be given alongside Farxiga...
Impressive results from the DELIVER trial show that dapagliflozin (Farxiga), a SGLT-2 inhibitor, could be used to treat all types of heart failure, a common diabetes...
Encouraging trial results from Novo Nordisk show that a new combination therapy in development could help people lower their A1C and weight dramatically. With the...
Approximately 17% of people with diabetes have diabetic cardiomyopathy, a dangerous complication that can lead to heart failure. This clinical trial is focused on...
The recently passed Inflation Reduction Act includes new policies that cap the monthly cost of insulin at $35 and potentially reduce the cost of other diabetes drugs for...
Clinical trial results have shown that once-weekly basal insulins are just as effective at reducing A1C as once-daily insulin.
Chronic obesity-related health conditions such as type 2 diabetes, insulin resistance, high blood pressure, and fatty liver disease were previously only seen in adults...
diaTribe’s Julie Heverly had the opportunity to try the new Tandem mobile app, which allows users to administer insulin boluses directly from their smartphones. Here’s...
Insulet recently announced that the Omnipod 5 automated insulin delivery (AID) system is now fully available to anyone with type 1 diabetes ages 2 and up. Read about...
Lilly has just announced that it will discontinue manufacturing its Glucagon Emergency Kits. Read why the company took this step and what your options are to access...
In the search for new and innovative ways to treat type 1 diabetes, researchers have looked to develop therapies that protect or improve the body’s ability to produce...
Insulin pens and pumps are two of the most popular choices for insulin delivery. The CeQur Simplicity aims to combine the strengths of both of these technologies.
The FDA approved Beovu (brolucizumab) to treat diabetic macular edema for people with type 1 or type 2 diabetes. This medication could potentially help you or someone...
Researchers are dedicated to developing new mealtime insulins that can help improve glucose management and prevent highs and lows. Exciting new concentrated, ultra-rapid...
While African Americans, Hispanic/Latino Americans, and Indigenous people can be nearly twice as likely to have diabetes as white Americans, these populations are less...
The financial burden of managing diabetes can be overwhelming. Sanofi has updated its Valyou Savings Program to make insulin more affordable for those who are uninsured...
Are you an adult with type 2 diabetes who is interested in trying oral insulin? If so, see if you’re eligible for this clinical trial studying how an oral insulin pill...

Pages